SecProbe.io

CORRESP
1
filename1.htm

    January 6, 2025

    Via EDGAR

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    100 F Street, N.E.

    Washington, DC 20549

    Attn: Doris Gama

            Re:

            Cartesian Therapeutics, Inc.

            Registration Statement on Form S-3 (the “Registration Statement”)

            File No. 333-283803

    Ladies and Gentlemen:

    Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cartesian Therapeutics, Inc. (the “Company”) hereby respectfully
      requests that the effective date of the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on January 8, 2025, or as soon as
      practicable thereafter.

    Please contact Sarah C. Griffiths of Covington & Burling LLP at (617) 603-8815 or sgriffiths@cov.com with any questions you may have
      regarding this request. In addition, please notify Ms. Griffiths by telephone when this request for acceleration has been granted.

            Very truly yours,

            CARTESIAN THERAPEUTICS, INC.

            By:

            /s/ Carsten Brunn

            Name:

            Carsten Brunn

            Title:

            President and Chief Executive Officer

            cc:

            Brian K. Rosenzweig, Covington & Burling LLP

            Sarah C. Griffiths, Covington & Burling LLP